JPS5618980A - Pyrazoloquinone* manufacture* pharmaceutic medicine containing same and therapeutic application - Google Patents
Pyrazoloquinone* manufacture* pharmaceutic medicine containing same and therapeutic applicationInfo
- Publication number
- JPS5618980A JPS5618980A JP8449380A JP8449380A JPS5618980A JP S5618980 A JPS5618980 A JP S5618980A JP 8449380 A JP8449380 A JP 8449380A JP 8449380 A JP8449380 A JP 8449380A JP S5618980 A JPS5618980 A JP S5618980A
- Authority
- JP
- Japan
- Prior art keywords
- hydroxy
- alkyl
- see diagramm
- hydrogen
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 8
- 229910052739 hydrogen Inorganic materials 0.000 abstract 8
- 239000001257 hydrogen Substances 0.000 abstract 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 7
- -1 nitro, amino Chemical group 0.000 abstract 7
- 150000003839 salts Chemical class 0.000 abstract 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 150000002367 halogens Chemical class 0.000 abstract 3
- 150000002431 hydrogen Chemical class 0.000 abstract 3
- 125000003277 amino group Chemical group 0.000 abstract 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- 125000006377 halopyridyl group Chemical group 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 abstract 2
- 125000004076 pyridyl group Chemical group 0.000 abstract 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000002462 isocyano group Chemical group *[N+]#[C-] 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
- C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/28—Two oxygen or sulfur atoms
- C07D231/30—Two oxygen or sulfur atoms attached in positions 3 and 5
- C07D231/32—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Electrophonic Musical Instruments (AREA)
- Golf Clubs (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5071679A | 1979-06-21 | 1979-06-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5618980A true JPS5618980A (en) | 1981-02-23 |
JPH039114B2 JPH039114B2 (ja) | 1991-02-07 |
Family
ID=21966959
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8449380A Granted JPS5618980A (en) | 1979-06-21 | 1980-06-21 | Pyrazoloquinone* manufacture* pharmaceutic medicine containing same and therapeutic application |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP0022078B1 (ja) |
JP (1) | JPS5618980A (ja) |
KR (1) | KR840000421B1 (ja) |
AT (1) | ATE8629T1 (ja) |
AU (1) | AU538890B2 (ja) |
CA (1) | CA1148159A (ja) |
CY (1) | CY1357A (ja) |
DD (1) | DD151754A5 (ja) |
DE (1) | DE3068673D1 (ja) |
DK (1) | DK160762C (ja) |
FI (1) | FI68827C (ja) |
GR (1) | GR69282B (ja) |
HK (1) | HK47387A (ja) |
HU (1) | HU183156B (ja) |
IE (1) | IE49993B1 (ja) |
IL (1) | IL60357A (ja) |
MY (1) | MY8700556A (ja) |
NO (1) | NO153430C (ja) |
NZ (1) | NZ194102A (ja) |
PT (1) | PT71420A (ja) |
SG (1) | SG14387G (ja) |
ZA (1) | ZA803714B (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010529144A (ja) * | 2007-06-08 | 2010-08-26 | ヘリコン・セラピューティクス・インコーポレーテッド | 治療用ピラゾロキノリン尿素誘導体 |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4459298A (en) * | 1982-09-28 | 1984-07-10 | Ciba-Geigy Corporation | Method of suppressing appetite |
US4524146A (en) * | 1982-12-08 | 1985-06-18 | Ciba-Geigy Corporation | Certain -2-heterocycle substituted pyrazoloquinolines |
US4479955A (en) * | 1983-01-10 | 1984-10-30 | Ciba-Geigy Corporation | Heterocycle-fused pyrazolo[3,4-d]pyridin-3-ones as benzodiazepine receptor modulators |
EP0126970A3 (en) * | 1983-04-27 | 1985-11-06 | Beecham Group Plc | Anxiolytic and anti-depressant thienopyridine derivatives |
FR2549833B1 (fr) * | 1983-07-26 | 1985-11-08 | Roussel Uclaf | Derives de la pyrazolo /4,3-c/ cinnolin-3-one, leurs sels, procede de preparation, application a titre de medicaments, compositions les renfermant et produits intermediaires |
CA1263651A (en) * | 1984-07-09 | 1989-12-05 | Ciba-Geigy Ag | Certain ring-fused pyrazolo ¬3,4-d|-pyridin-3-one derivatives |
PH21213A (en) * | 1984-10-26 | 1987-08-21 | Fujisawa Pharmaceutical Co | Benzene- and pyrazole- fused heterocyclic compound and pharmaceutical composition comprising the same |
JPS61112075A (ja) * | 1984-11-05 | 1986-05-30 | Shionogi & Co Ltd | チエニルピラゾロキノリン誘導体 |
DE3728278A1 (de) * | 1986-12-17 | 1988-06-23 | Bayer Ag | Herbizide und fungizide mittel auf basis von substituierten pyrazolin-5-on derivaten |
US5243049A (en) * | 1992-01-22 | 1993-09-07 | Neurogen Corporation | Certain pyrroloquinolinones: a new class of GABA brain receptor ligands |
GB9625398D0 (en) * | 1996-12-06 | 1997-01-22 | Merck Sharp & Dohme | Method of treatment,manufacture,compositions and compounds |
US6835707B1 (en) | 1998-10-13 | 2004-12-28 | The Procter & Gamble Company | Laundry detergent compositions with a combination of cyclic amine based polymers and hydrophobically modified carboxy methyl cellulose |
GB0305876D0 (en) * | 2003-03-14 | 2003-04-16 | Avidex Ltd | Immuno inhibitory heterocyclic compounds |
EP2483275B1 (en) * | 2009-10-01 | 2014-10-15 | Merck Sharp & Dohme Corp. | HETEROCYCLIC-FUSED PYRAZOLO[4,3-c]PYRIDIN-3-ONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS |
EP2490692B1 (en) * | 2009-10-21 | 2016-11-16 | Merck Sharp & Dohme Corp. | Quinolinone-pyrazolone m1 receptor positive allosteric modulators |
EP2699572B1 (en) | 2011-04-21 | 2016-08-10 | Origenis GmbH | Heterocyclic compounds as kinase inhibitors |
US10000482B2 (en) | 2012-10-19 | 2018-06-19 | Origenis Gmbh | Kinase inhibitors |
CN114891236B (zh) * | 2022-06-09 | 2023-04-28 | 安庆师范大学 | 一种三维Co-MOF化合物及其制备方法和应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3890324A (en) * | 1974-04-12 | 1975-06-17 | Lilly Co Eli | 1h-pyrazolo(4,3-)quinol-4(5h)-one-3-carboxylic acids |
EP0005745B1 (en) * | 1978-05-26 | 1982-07-14 | Gruppo Lepetit S.P.A. | Pyrazolo (3,4-c) and thiazolo (5,4-c) isoquinolines, methods for preparing them, these compounds for use as antiinflammatory, cns-depressant and anti-anxiety agents and pharmaceutical compositions thereof |
-
1980
- 1980-06-16 CY CY135780A patent/CY1357A/xx unknown
- 1980-06-16 EP EP80810200A patent/EP0022078B1/de not_active Expired
- 1980-06-16 AT AT80810200T patent/ATE8629T1/de not_active IP Right Cessation
- 1980-06-16 DE DE8080810200T patent/DE3068673D1/de not_active Expired
- 1980-06-18 FI FI801964A patent/FI68827C/fi not_active IP Right Cessation
- 1980-06-19 CA CA000354349A patent/CA1148159A/en not_active Expired
- 1980-06-19 PT PT71420A patent/PT71420A/pt unknown
- 1980-06-19 GR GR62257A patent/GR69282B/el unknown
- 1980-06-19 IL IL60357A patent/IL60357A/xx unknown
- 1980-06-20 NZ NZ194102A patent/NZ194102A/xx unknown
- 1980-06-20 IE IE1279/80A patent/IE49993B1/en not_active IP Right Cessation
- 1980-06-20 NO NO801866A patent/NO153430C/no unknown
- 1980-06-20 KR KR1019800002438A patent/KR840000421B1/ko active
- 1980-06-20 DK DK264880A patent/DK160762C/da not_active IP Right Cessation
- 1980-06-20 ZA ZA00803714A patent/ZA803714B/xx unknown
- 1980-06-20 AU AU59455/80A patent/AU538890B2/en not_active Ceased
- 1980-06-21 JP JP8449380A patent/JPS5618980A/ja active Granted
- 1980-06-23 DD DD80222091A patent/DD151754A5/de unknown
- 1980-08-21 HU HU801539A patent/HU183156B/hu unknown
-
1987
- 1987-02-17 SG SG143/87A patent/SG14387G/en unknown
- 1987-06-18 HK HK473/87A patent/HK47387A/xx unknown
- 1987-12-30 MY MY556/87A patent/MY8700556A/xx unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010529144A (ja) * | 2007-06-08 | 2010-08-26 | ヘリコン・セラピューティクス・インコーポレーテッド | 治療用ピラゾロキノリン尿素誘導体 |
Also Published As
Publication number | Publication date |
---|---|
NZ194102A (en) | 1983-04-12 |
IL60357A (en) | 1984-05-31 |
IE801279L (en) | 1980-12-21 |
DD151754A5 (de) | 1981-11-04 |
IE49993B1 (en) | 1986-01-22 |
CY1357A (en) | 1987-08-07 |
KR840000421B1 (ko) | 1984-04-02 |
DE3068673D1 (en) | 1984-08-30 |
MY8700556A (en) | 1987-12-31 |
FI68827B (fi) | 1985-07-31 |
ZA803714B (en) | 1981-06-24 |
ATE8629T1 (de) | 1984-08-15 |
EP0022078B1 (de) | 1984-07-25 |
NO153430C (no) | 1986-03-19 |
AU538890B2 (en) | 1984-08-30 |
JPH039114B2 (ja) | 1991-02-07 |
DK160762B (da) | 1991-04-15 |
CA1148159A (en) | 1983-06-14 |
PT71420A (en) | 1980-07-01 |
NO801866L (no) | 1980-12-22 |
IL60357A0 (en) | 1980-09-16 |
KR830002763A (ko) | 1983-05-30 |
AU5945580A (en) | 1981-01-08 |
SG14387G (en) | 1987-07-10 |
DK160762C (da) | 1991-09-23 |
FI801964A (fi) | 1980-12-22 |
HU183156B (en) | 1984-04-28 |
HK47387A (en) | 1987-06-26 |
NO153430B (no) | 1985-12-09 |
DK264880A (da) | 1980-12-22 |
EP0022078A1 (de) | 1981-01-07 |
GR69282B (ja) | 1982-05-13 |
FI68827C (fi) | 1985-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS5618980A (en) | Pyrazoloquinone* manufacture* pharmaceutic medicine containing same and therapeutic application | |
HUT41761A (en) | Process for producing tricyclic aromatic compounds | |
DK156717C (da) | Analogifremgangsmaade til fremstilling af indomethacinderivater | |
EP1103552A4 (en) | BENZOTHIEPINE DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE | |
HUT60498A (en) | Process for producing 2-(substituted pyrrolidinylthio)-carbapenem derivatives and pharmaceutical compositions comprising such compounds | |
DE3161895D1 (en) | 5-substituted-9-cyane-methylene-dithieno(3,4-b:4',3'-e) azepines, process for their preparation and pharmaceutical compositions containing them | |
DE3479499D1 (en) | Triazolo (2,3-c)(1,3)benzodiazepines, process for their preparation, pharmaceutical compositions containing them and their therapeutical use | |
DE3068648D1 (de) | Derivatives of 3-amino-(1h,3h)-2,4-quinazolin-diones | |
AU566404B2 (en) | 1,7-dihydro-pyrrolo (3,4-e) (1,4) diazepin-z(3h) - one derivatives | |
ES470462A1 (es) | Procedimiento para producir imidazol-2-carbamatos |